Evidence map›Paper›PMID 38749006›Full record

ArticleAdvanced healthcare materials2024

Granular Biphasic Colloidal Hydrogels for 3D Bioprinting.

Kaivalya A Deo, Aparna Murali, James J Tronolone, Cole Mandrona, Hung Pang Lee, Satyam Rajput, Sarah E Hargett, Amirali Selahi, Yuxiang Sun, Daniel L Alge and 2 more

Abstract read
In one paragraph

Article in Advanced healthcare materials, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Kaivalya A DeoBiomedical Engineering, College of Engineering, Texas A&M University, College Station, TX, 77843, USA.ORCID 0000-0002-2233-383X
Aparna MuraliBiomedical Engineering, College of Engineering, Texas A&M University, College Station, TX, 77843, USA.ORCID 0000-0002-5250-0061
James J TronoloneBiomedical Engineering, College of Engineering, Texas A&M University, College Station, TX, 77843, USA.ORCID 0000-0001-5405-4520
Cole MandronaBiomedical Engineering, College of Engineering, Texas A&M University, College Station, TX, 77843, USA.ORCID 0009-0007-2088-1473
Hung Pang LeeBiomedical Engineering, College of Engineering, Texas A&M University, College Station, TX, 77843, USA.ORCID 0009-0003-3764-4352
Satyam RajputBiomedical Engineering, College of Engineering, Texas A&M University, College Station, TX, 77843, USA.ORCID 0000-0002-9187-5245
Sarah E HargettBiomedical Engineering, College of Engineering, Texas A&M University, College Station, TX, 77843, USA.ORCID 0000-0002-5389-6344
Amirali SelahiBiomedical Engineering, College of Engineering, Texas A&M University, College Station, TX, 77843, USA.ORCID 0000-0002-5887-4283
Yuxiang SunNutrition, College of Agriculture, Texas A&M University, College Station, TX, 77843, USA.ORCID 0000-0002-6656-3733
Daniel L AlgeBiomedical Engineering, College of Engineering, Texas A&M University, College Station, TX, 77843, USA.ORCID 0000-0002-8129-2871
Abhishek JainBiomedical Engineering, College of Engineering, Texas A&M University, College Station, TX, 77843, USA.ORCID 0000-0003-2235-5139
Akhilesh K GaharwarBiomedical Engineering, College of Engineering, Texas A&M University, College Station, TX, 77843, USA.ORCID 0000-0002-0284-0201

Funding

Texas A&M Center for Environmental Health Research (TiCER)P30ES029067 · NIEHS · TEXAS A&M UNIVERSITY · PI Weihsueh A Chiu · 2019 to 2026
$13.0M
Determinants of COVID19-induced venous thrombosis and targeted therapy assessed with bioengineered vein-chipR01HL157790 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI CONNOR, JOHN H, COOKE, JOHN P · 2021 to 2024
$2.8M
Mineralomics: Designing mineral based therapeutics to control and direct cell functionDP2EB026265 · NIBIB · TEXAS ENGINEERING EXPERIMENT STATION · PI GAHARWAR, AKHILESH K. · 2017 to 2021
$2.4M
Osteoinductive Nanosilicate-Based Biomaterials for In Situ Craniomaxillofacial Bone RegenerationR01DE032031 · NIDCR · TEXAS ENGINEERING EXPERIMENT STATION · PI CARL A. GREGORY, Akhilesh K. Gaharwar · 2024 to 2026
$1.7M
American Heart Association 24PRE1200460BARDANASA 80ARC023CA002National Science Foundation CBET 1705852National Science Foundation Graduate Research Fellowship 1650114NHLBI NIH HHS R01 HL157790NIBIB NIH HHS DP2 EB026265NIDCR NIH HHS R01 DE032031NIEHS NIH HHS P30 ES029067NIH HHS R01HL157790NSF CAREER 1944322NSF CAREER 906239Texas A&M University President's Excellence FundTexas A and M UniversityUSFDA
6 · The paper itself

Abstract

Granular hydrogels composed of hydrogel microparticles are promising candidates for 3D bioprinting due to their ability to protect encapsulated cells. However, to achieve high print fidelity, hydrogel microparticles need to jam to exhibit shear-thinning characteristics, which is crucial for 3D printing. Unfortunately, this overpacking can significantly impact cell viability, thereby negating the primary advantage of using hydrogel microparticles to shield cells from shear forces. To overcome this challenge, a novel solution: a biphasic, granular colloidal bioink designed to optimize cell viability and printing fidelity is introduced. The biphasic ink consists of cell-laden polyethylene glycol (PEG) hydrogel microparticles embedded in a continuous gelatin methacryloyl (GelMA)-nanosilicate colloidal network. Here, it is demonstrated that this biphasic bioink offers outstanding rheological properties, print fidelity, and structural stability. Furthermore, its utility for engineering complex tissues with multiple cell types and heterogeneous microenvironments is demonstrated, by incorporating β-islet cells into the PEG microparticles and endothelial cells in the GelMA-nanosilicate colloidal network. Using this approach, it is possible to induce cell patterning, enhance vascularization, and direct cellular function. The proposed biphasic bioink holds significant potential for numerous emerging biomedical applications, including tissue engineering and disease modeling.

Indexed as

BioprintingColloidsGelatinHydrogelsPolyethylene GlycolsPrinting, Three-DimensionalAnimalsCell SurvivalHumansHuman Umbilical Vein Endothelial CellsMethacrylatesRheologyTissue EngineeringColloidsGelatingelatin methacryloylHydrogelsMethacrylatesPolyethylene Glycols3D bioprintingdrug deliverygranular colloidal hydrogelshydrogel microparticlesnanocomposite

Identifiers

PMID38749006
PMCPMC12885003

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.